17-4513293-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_ModerateBP6BP7
The NM_001124758.3(SPNS2):c.417C>T(p.Gly139=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000196 in 1,613,836 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.00016 ( 0 hom., cov: 34)
Exomes 𝑓: 0.00020 ( 0 hom. )
Consequence
SPNS2
NM_001124758.3 synonymous
NM_001124758.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.27
Genes affected
SPNS2 (HGNC:26992): (SPNS lysolipid transporter 2, sphingosine-1-phosphate) The protein encoded by this gene is a transporter of sphingosine 1-phosphate, a secreted lipid that is important in cardiovascular, immunological, and neural development. Defects in this gene are a cause of early onset progressive hearing loss. [provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.4).
BP6
Variant 17-4513293-C-T is Benign according to our data. Variant chr17-4513293-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 3352578.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=-1.27 with no splicing effect.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SPNS2 | NM_001124758.3 | c.417C>T | p.Gly139= | synonymous_variant | 2/13 | ENST00000329078.8 | |
SPNS2 | XM_047435339.1 | c.-37C>T | 5_prime_UTR_variant | 2/13 | |||
SPNS2 | XR_007065260.1 | n.584C>T | non_coding_transcript_exon_variant | 2/13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SPNS2 | ENST00000329078.8 | c.417C>T | p.Gly139= | synonymous_variant | 2/13 | 1 | NM_001124758.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152204Hom.: 0 Cov.: 34
GnomAD3 genomes
AF:
AC:
25
AN:
152204
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000185 AC: 46AN: 248792Hom.: 0 AF XY: 0.000185 AC XY: 25AN XY: 135244
GnomAD3 exomes
AF:
AC:
46
AN:
248792
Hom.:
AF XY:
AC XY:
25
AN XY:
135244
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000199 AC: 291AN: 1461632Hom.: 0 Cov.: 31 AF XY: 0.000205 AC XY: 149AN XY: 727096
GnomAD4 exome
AF:
AC:
291
AN:
1461632
Hom.:
Cov.:
31
AF XY:
AC XY:
149
AN XY:
727096
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000164 AC: 25AN: 152204Hom.: 0 Cov.: 34 AF XY: 0.000188 AC XY: 14AN XY: 74340
GnomAD4 genome
AF:
AC:
25
AN:
152204
Hom.:
Cov.:
34
AF XY:
AC XY:
14
AN XY:
74340
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
SPNS2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 08, 2024 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at